Alamar Biosciences, Inc. (ALMR) vs TransMedics Group, Inc. (TMDX)
A side-by-side comparison of Alamar Biosciences, Inc. and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALMR
Alamar Biosciences, Inc.
$36.40HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
TMDX
TransMedics Group, Inc.
$81.92HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ALMR vs TMDX
growth of $100 · dividends reinvested · last 1yALMR +73.3% (+73.3%/yr)TMDX -23.9% (-23.9%/yr)ALMR compounded faster over this window
ALMR TMDX
ALMR vs TMDX: by the numbers
- •TMDX is the larger company ($2.83B vs $2.52B market cap).
- •TMDX is profitable (22.69% net margin) while ALMR runs a net loss (-40.18%).
Metrics side by side
Valuation
| Metric | ALMR | TMDX |
|---|---|---|
| P/E ratio | N/A | 21.22 |
| Forward P/E | N/A | 55.84 |
| P/S ratio | N/A | 4.24 |
| P/B ratio | 8.06 | 5.46 |
| EV / EBITDA | N/A | 27.33 |
| FCF yield | N/A | 2.79% |
Profitability
| Metric | ALMR | TMDX |
|---|---|---|
| Gross margin | 56.20% | 58.69% |
| Operating margin | -42.22% | 12.21% |
| Net margin | -40.18% | 22.69% |
| ROE | N/A | 29.28% |
| ROIC | -26.95% | 5.87% |
Growth (annualized)
| Metric | ALMR | TMDX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 86.12% |
| Total return CAGR (5Y) | N/A | 21.77% |
Frequently asked
- Is ALMR or TMDX more profitable?
- TMDX runs the higher net margin — ALMR at -40.18% versus TMDX at 22.69%.
Go deeper
Dig into the metrics
TransMedics P/E ratioAlamar Biosciences ROETransMedics ROEAlamar Biosciences operating marginTransMedics operating marginAlamar Biosciences revenue growthTransMedics revenue growthAlamar Biosciences free cash flowTransMedics free cash flow
Alamar Biosciences & TransMedics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.